American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

MEDICINOVA INC (MNOV)

$1.39 -1.42% NASDAQ: MNOV · 15-min delayed

LA JOLLA, California
Public · NASDAQ: MNOV
6 employees

Visit website Follow

$65.0MMarket cap

$409.7KRevenue · FY2025

-$12.0MNet income

6Employees

MNOVNASDAQ

2006IPO

About MEDICINOVA INC

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: MNOV
Employees: 6
IPO date: Dec 7, 2006
Headquarters: 4275 EXECUTIVE SQUARE
LA JOLLA, California 92037
Phone: 858-373-1500
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: MNOV Nasdaq
SEC CIK: 1226616
EIN: 330927979
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Medicinova Inc’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/medicinova-inc/"><img src="https://americancompanies.com/badge/medicinova-inc.svg" alt="Medicinova Inc — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow MEDICINOVA INC and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $409.7K
Net income: -$12.0M
Total assets: $45.6M
Market cap: $65.0M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: MNOV

$1.39 -1.42%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.18 $3.45

52-week range

Market cap: $65.0M
Shares outstanding: 46.7M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Dec 7, 2006

Medicinova Inc (MNOV) Stock Price

Reported a net loss of $12.0M in FY2025.
Trading 60% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review MEDICINOVA INC.

Write a review

Newsroom

News about MEDICINOVA INC

MediciNova CEO Provides Shareholder Update GlobeNewswire Inc. · 2026-10-12 · neutral MediciNova to Participate in the Maxim Growth Summit GlobeNewswire Inc. · 2026-10-06 · positive MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) GlobeNewswire Inc. · 2026-09-28 · positive Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight GlobeNewswire Inc. · 2026-06-08 · positive MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) GlobeNewswire Inc. · 2026-05-26 · positive New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation GlobeNewswire Inc. · 2026-04-27 · positive

News & sentiment via Polygon.io

FAQ

Medicinova Inc: frequently asked questions

Is Medicinova Inc an American company?

Medicinova Inc is a US-based company headquartered in La Jolla, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Medicinova Inc headquartered?

Medicinova Inc is headquartered in La Jolla, California, United States.

Is Medicinova Inc publicly traded?

Yes — Medicinova Inc is a publicly traded company. Its stock trades under the ticker symbol MNOV on the NASDAQ.

What does Medicinova Inc do?

Medicinova Inc is an American Pharmaceuticals company in the Health & Beauty sector.

Explore